|
Recombinant human insulin-like growth factor-I |
|---|---|
| Trade Name | Pv802 |
| Orphan Indication | Short-bowel syndrome as a result of resection of the small bowel or as a result of congenital dysfunction of the intestines |
| USA Market Approval | USA |
| USA Designation Date | 2000-02-16 00:00:00 |
| Sponsor | GroPep Pty Ltd.;Gate 11, Victoria Dr., Adelaide SA 5000; |
